Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Viral Infections

Successful ribavirin therapy for severe adenovirus hemorrhagic cystitis after allogeneic marrow transplant from close HLA donors rather than distant donors

Abstract

Intravenous ribavirin was given to nine patients who had developed severe adenovirus-induced hemorrhagic cystitis (AD-HC) which was resistant to conventional therapy or where there was involvement of other organs after allogeneic BMT. Three patients recovered completely from AD-HC, two of whom had been resistant to vidarabine. All three had received sibling BMTs (2 HLA matched, 1 HLA mismatched). Five patients who received BMTs from related (2 HLA mismatched) or unrelated (1 HLA matched, 2 HLA mismatched) showed an improvement in symptoms but had recurrent AD-HC after discontinuation of ribavirin. Improvement in clinical symptoms and termination of virus excretion were well correlated. The last patient who received a mismatched unrelated BMT died during ribavirin therapy. Ribavirin was notably more effective among patients receiving BMTs from siblings in contrast to patients receiving BMTs from alternative donors (<0.05). One patient experienced severe pancytopenia during the second treatment with ribavirin after hc recurrence and recovered after ceasing ribavirin. Thus, ribavirin seems to be very effective for severe ad-hc for some recipients who receive transplants from a genetically close donor. Bone Marrow Transplantation (2000) 25, 545–548.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Brugieres L, Hartmann O, Travagli JP et al. Hemorrhagic cystitis following high-dose chemotherapy and bone marrow transplantation in children with malignancies: incidence, clinical course, and outcome J Clin Oncol 1989 7: 194–199

    Article  CAS  Google Scholar 

  2. Miyamura K, Takeyama K, Kojima S et al. Hemorrhagic cystitis associated with urinary excretion of adenovirus type 11 following allogeneic bone marrow transplantation BoneMarrow Transplant 1989 4: 533–535

    CAS  Google Scholar 

  3. Atkinson K, Biggs J, Noble G et al. Preparative regimens for marrow transplantation containing busulphan are associated with haemorrhagic cystitis and hepatic veno-occlusive disease but a short duration of leucopenia and little oro-pharyngeal mucositis Bone Marrow Transplant 1987 2: 385–394

    CAS  PubMed  Google Scholar 

  4. Seber A, Shu XO, Defor T et al. Risk factors for severe hemorrhagic cystitis following BMT Bone Marrow Transplant 1999 23: 35–40

    Article  CAS  Google Scholar 

  5. Arthur RR, Shah KV, Baust SJ et al. Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants New Engl J Med 1986 315: 230–234

    Article  CAS  Google Scholar 

  6. Numazaki Y, Shigeta S, Kumasaka T et al. Acute hemorrhagic cystitis in children. Isolation of adenovirus type II New Engl J Med 1968 278: 700–704

    Article  CAS  Google Scholar 

  7. Zahradnik JM, Spencer MJ, Porter DD . Adenovirus infection in the immunocompromised patient Am J Med 1980 68: 725–732

    Article  CAS  Google Scholar 

  8. Fiala M, Payne JE, Berne TV et al. Role of adenovirus type 11 in hemorrhagic cystitis secondary to immunosuppression J Urol 1974 112: 595–597

    Article  CAS  Google Scholar 

  9. Miyamura K, Minami S, Matsuyama T et al. Adenovirus-induced late onset hemorrhagic cystitis following allogeneic bone marrow transplantation (letter) Bone Marrow Transplant 1987 2: 109–110

    CAS  PubMed  Google Scholar 

  10. Ambinder RF, Burns W, Forman M et al. Hemorrhagic cystitis associated with adenovirus infection in bone marrow transplantation Arch Intern Med 1986 146: 1400–1401

    Article  CAS  Google Scholar 

  11. Shields AF, Hackman RC, Fife KH et al. Adenovirus infections in patients undergoing bone marrow transplantation New Eng J Med 1985 312: 529–533

    Article  CAS  Google Scholar 

  12. Flomenberg P, Babbitt J, Drobyski WR et al. Increasing incidence of adenovirus disease in bone marrow transplant recipients J Infect Dis 1994 169: 775–781

    Article  CAS  Google Scholar 

  13. Kohno A, Takeyama K, Narabayashi M et al. Hemorrhagic cystitis associated with allogeneic and autologous bone marrow transplantation for malignant neoplasms in adults Jap J Clin Oncol 1993 23: 46–52

    CAS  Google Scholar 

  14. Childs R, Sanchez C, Engler H et al. High incidence of adeno- and polyomavirus-induced hemorrhagic cystits in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporine Bone Marrow Transplant 1998 22: 889–894

    Article  CAS  Google Scholar 

  15. Trigg ME, O'Reilly J, Rumelhart S et al. Prostaglandin E1 bladder instillations to control severe hemorrhagic cystitis J Urol 1990 143: 92–94

    Article  CAS  Google Scholar 

  16. Cassano WF . Intravenous ribavirin therapy for adenovirus cystitis after allogeneic bone marrow transplantation Bone Marrow Transplant 1991 7: 247–248

    CAS  PubMed  Google Scholar 

  17. Murphy GF, Wood DP Jr, McRoberts JW et al. Adenovirus-associated hemorrhagic cystitis treated with intravenous ribavirin J Urol 1993 149: 565–566

    Article  CAS  Google Scholar 

  18. Liles WC, Cushing H, Holt S et al. Severe adenoviral nephritis following bone marrow transplantation: successful treatment with intravenous ribavirin (see comments) Bone Marrow Transplant 1993 12: 409–412

    CAS  PubMed  Google Scholar 

  19. Hromas R, Clark C, Blanke C et al. Failure of ribavirin to clear adenovirus infections in T cell-depleted allogeneic bone marrow transplantation (letter; comment) Bone Marrow Transplant 1994 14: 663–664

    CAS  PubMed  Google Scholar 

  20. Jurado M, Navarro JM, Hernandez J et al. Adenovirus-associated haemorrhagic cystitis after bone marrow transplantation successfully treated with intravenous ribavirin Bone Marrow Transplantation 1995 15: 651–652

    CAS  PubMed  Google Scholar 

  21. Mann D, Moreb J, Smith S et al. Failure of intravenous ribavirin in the treatment of invasive adenovirus infection following allogeneic bone marrow transplantation: a case report J Infect 1998 36: 227–228

    Article  CAS  Google Scholar 

  22. Sao H, Kitaori K, Kasai M et al. A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-versus-host disease in allogeneic bone marrow transplantation results of phase I–II trial Int J Hematol 1999 69: 27–35

    CAS  PubMed  Google Scholar 

  23. Paroni R, Del Puppo M, Borghi C et al. Pharmacokinetics of ribavirin and urinary excretion of major metabolite 1,2,4-triazole-3-carboxamide in normal volunteers Int J Clin Pharmacol 1989 27: 302–307

    CAS  Google Scholar 

  24. Hromas R, Cornetta K, Srour E et al. Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T cell-depleted bone marrow transplantation (letter) Blood 1994 84: 1689–1690

    CAS  PubMed  Google Scholar 

  25. Flomenberg P, Piaskowski V, Truitt RL et al. Human adenovirus-specific CD8+ T-cell responses are not inhibited by E3–19K in the presence of gamma interferon J Virol 1996 70: 6314–6322

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors are grateful to Miss Naoko Iwashima for the management of the import of ribavirin and Dr Gouji Kato, Makoto Hayashi and Yuko Kojima for patient information.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miyamura, K., Hamaguchi, M., Taji, H. et al. Successful ribavirin therapy for severe adenovirus hemorrhagic cystitis after allogeneic marrow transplant from close HLA donors rather than distant donors. Bone Marrow Transplant 25, 545–548 (2000). https://doi.org/10.1038/sj.bmt.1702195

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702195

Keywords

This article is cited by

Search

Quick links